# Integer Holdings Corporation (ITGR) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Technology. Price $126.50, market value $4.3 billion.

## Valuation
- **P/E (trailing): 34.6×** (5-yr avg 33.4×, 3-yr avg 34.5×). Integer Holdings Corporation trades at 34.6× trailing earnings, close to its own five-year average of 33.4×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 18.4×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 2.3×**. Each dollar of revenue is priced at 2.3×.
- **Price / book: 2.5×**. The shares trade at 2.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 17.3×**. Enterprise value is 17.3× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 2.6%** (5-yr avg 2.6%). Free cash flow equals 2.6% of the market value, in line with its five-year average of 2.6%.
- **Earnings yield: 2.9%**. The inverse of the P/E: 2.9% of the price is earned each year.

## Profitability
- **Gross margin: 25.7%**. Integer Holdings Corporation keeps 25.7% of revenue after the direct cost of what it sells.
- **Operating margin: 9.7%**. 9.7% of revenue is left after running the business.
- **Net margin: 5.5%**. 5.5% of each dollar of sales reaches the bottom line.
- **Return on equity: 5.9%**. 5.9% on shareholders' equity is weak; the business earns little on the capital its owners have in it.
- **Return on invested capital: 4.8%**. Return on all capital, debt included, is 4.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 3.8%**. Each dollar of assets produces 3.8% of profit.

## Growth
- **Revenue growth (1 yr): 8.0%** (3-yr 11.7%/yr, 5-yr 11.5%/yr). Revenue grew 8.0% over the last year, against 11.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -14.0%** (3-yr 13.2%/yr, 5-yr 4.4%/yr). Earnings per share fell 14.0%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 36.1%/yr**. Free cash flow has compounded at 36.1% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.68**. Debt is 0.68 times equity, moderate leverage.
- **Net debt / EBITDA: 3.7×**. It would take 3.7 years of operating earnings to repay net borrowings, above the 3× level most lenders treat as comfortable.
- **Altman Z-score: 3.03**. A Z-score of 3.03 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Integer Holdings Corporation does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 18.7%** (YTD 61.3%, 3-mo 37.5%). The shares are up 18.7% over twelve months including dividends.
- **From 52-week high: -0.2%** (104.0% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 82**. An RSI of 82 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 0.66** (volatility 47%). Beta of 0.66 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ITGR · Page: https://foliofundamentals.com/stocks/itgr

Not investment advice.